⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of OrBion Pharmaceuticals Private Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
OrBion Pharmaceuticals Private Limited
↗Chennai, India
OrBion Pharmaceuticals is a finished dose formulation company specializing in the research, manufacturing, and marketing of generic pharmaceutical products. It operates as a vertically integrated entity spanning from discovery to distribution, with a global presence across 40 countries.
The company was established in 2021 as a joint venture between Bionpharma USA and Orchid Pharma Ltd. It operates a state-of-the-art, eco-friendly manufacturing facility in Chennai, India, which is GMP-compliant and focused on non-penicillin and non-cephalosporin formulations, including cardiovascular, neurology, and anti-diabetic segments.
CLASSIFICATION
SIZE & FINANCIALS
Founded:2021
Ownership:private
Status:operating
FUNDING
Investors:Bionpharma USA, Orchid Pharma Ltd
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Bionpharma USA (Joint Venture Partner), Orchid Pharma Ltd (Joint Venture Partner)
COMPETITION
Position:Emerging
Competitors:Sun Pharma, Mankind Pharma, Zydus Group, Biocon
LINKS
Website:orbionpharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with OrBion Pharmaceuticals Private Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.